Abstract
Continued progress is being made in understanding the breast cancer metabolism using analytical magnetic resonance (MR)-based methods like nuclear magnetic resonance (NMR) and in-vivo MR spectroscopy (MRS). Analyses using these methods have enhanced the knowledge of altered biochemical pathways associated with breast cancer progression, regression, and pathogenesis. Comprehensive metabolic profiling of biological samples like tissues, cell lines, fine needle aspirate, and biofluids such as sera and urine enables identification of new biomarkers and abnormalities in biochemical pathways. These methods are not only useful for diagnosis, therapy monitoring, disease progression, and staging of cancer but also for the identification of new therapeutic targets and designing new treatment strategies. Additionally, in-vivo MRS studies have established choline-containing compounds (tCho) as biomarkers of malignancy, which is useful for enhancing the diagnostic specificity of magnetic resonance imaging (MRI). Recent technological developments related to in-vivo MRS such as increased magnetic field strength, multichannel phased array breast coils, and absolute quantification of tCho have provided a better understanding of the tumor heterogeneity, metabolism, and pathogenesis. This chapter focuses on providing the experimental aspects of in-vitro, ex-vivo, and in-vivo MR spectroscopy methods used for metabolomics studies of breast cancer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Jagannathan NR, Sharma U (2017) Breast tissue metabolism by magnetic resonance spectroscopy. Meta 7:25
Bezabeh T, Ijare OB, Nikulin AE et al (2014) MRS-based metabolomics in cancer research. Magn Reson Insights 7:1–14
Tenori L, Oakman C, Morris PG et al (2015) Serum metabolomic profiles evaluated after surgery may identify patients with oestrogen receptor negative early breast cancer at increased risk of disease recurrence. Results from a retrospective study. Mol Oncol 9:128–139
GD T, Miller JA, Chow HH et al (2014) Metabolomic characterization of nipple aspirate fluid by (1) H NMR spectroscopy and GC-MS. J Proteome Res 13:883–889
Nagana Gowda GA, Barding GA Jr, Dai J et al (2018) A metabolomics study of BPTES altered metabolism in human breast cancer cell lines. Front Mol Biosci 5:49
Giskeødegård GF, Grinde MT, Sitter B et al (2010) Multivariate modeling and prediction of breast cancer prognostic factors using MR metabolomics. J Proteome Res 9:972–979
Choi JS, Baek HM, Kim S et al (2013) Magnetic resonance metabolic profiling of breast cancer tissue obtained with core needle biopsy for predicting pathologic response to neoadjuvant chemotherapy. PLoS One 8:e83866
Maria RM, Altei WF, Selistre-de-Araujo HS et al (2017) Impact of chemotherapy on metabolic reprogramming: characterization of the metabolic profile of breast cancer MDA-MB-231 cells using 1H HR-MAS NMR spectroscopy. J Pharm Biomed Anal 146:324–328
Fuss TL, Cheng LL (2016) Evaluation of cancer metabolomics using ex vivo high resolution magic angle spinning (HRMAS) magnetic resonance spectroscopy (MRS). Meta 6:11
Roebuck JR, Cecil KM, Schnall MD et al (1998) Human breast lesions: characterization with proton MR spectroscopy. Radiology 209:269–275
Jagannathan NR, Kumar M, Seenu V et al (2001) Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer. Br J Cancer 84:1016–1022
Sah RG, Sharma U, Parshad R et al (2012) Association of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status with total choline concentration and tumor volume in breast cancer patients: an MRI and in vivo proton MRS study. Magn Reson Med 68:1039–1047
Bolan PJ (2013) Magnetic resonance spectroscopy of the breast: current status. Magn Reson Imaging Clin N Am 21:625–639
Bolan PJ, Meisamy S, Baker EH et al (2003) In vivo quantification of choline compounds in the breast with 1H MR spectroscopy. Magn Reson Med 50:1134–1143
Baik HM, Su MY, Yu HJ et al (2006) Quantification of choline containing compounds in malignant breast tumors by 1H MR spectroscopy using water as an internal reference at 1.5 T. MAGMA 19:96–104
Bakken IJ, Gribbestad IS, Singstad TE et al (2001) External standard method for the in vivo quantification of choline-containing compounds in breast tumors by proton MR spectroscopy at 1.5 tesla. Magn Reson Med 46:189–192
Danishad KK, Sharma U, Sah RG et al (2010) Assessment of therapeutic response of locally advanced breast cancer (LABC) patients undergoing neoadjuvant chemotherapy (NACT) monitored using sequential magnetic resonance spectroscopic imaging (MRSI). NMR Biomed 23:233–241
Tozaki M, Sakamoto M, Oyama Y et al (2010) Predicting pathological response to neoadjuvant chemotherapy in breast cancer with quantitative 1H MR spectroscopy using the external standard method. J Magn Reson Imaging 31:895–902
Sharma U, Baek HM, Su MY et al (2011) In vivo 1H MRS in the assessment of the therapeutic response of breast cancer patients. NMR Biomed 24:700–711
Beckonert O, Keun HC, Ebbels TM et al (2007) Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat Protoc 2:2692–2703
Blekherman G, Laubenbacher R, Cortes DF et al (2011) Bioinformatics tools for cancer metabolomics. Metabolomics 7:329–343
Bolan PJ, DelaBarre L, Baker EH et al (2002) Eliminating spurious lipid sidebands in 1H MRS of breast lesions. Magn Reson Med 48:215–222
Emwas AH, Roy R, McKay RT et al (2016) Recommendations and Standardization of Biomarker Quantification Using NMR-Based Metabolomics with Particular Focus on Urinary Analysis. J Proteome Res 15:360–73. https://doi.org/10.1021/acs.jproteome.5b00885[PNJ1][PNJ1]
Acknowledgments
The Science and Engineering Research Board (SERB), Government of India is acknowledged for financial support (SP/S0/B27/95; SP/S0/B21/2001; SP/SO/HS-80/2006 and SR/SO/HS/213/2012) and a J.C. Bose Fellowship to NRJ.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Sharma, U., Jagannathan, N.R. (2019). Breast Cancer Metabolomics Using NMR. In: Gowda, G., Raftery, D. (eds) NMR-Based Metabolomics. Methods in Molecular Biology, vol 2037. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9690-2_12
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9690-2_12
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-9689-6
Online ISBN: 978-1-4939-9690-2
eBook Packages: Springer Protocols